SV
DPLO

Starboard Value’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Starboard Value’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-170,000
Closed -$7.61M – 42
2015
Q2 		$7.61M Buy
+170,000
New +$6.4M 0.17% 30

Other funds holding DPLO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Starboard Value's DPLO Position: Q3 2015 in Review

Starboard Value sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2015, closing a stake of 170,000 shares — an estimated $7.61M sold.

Starboard Value first reported a position in DPLO in Q2 2015 and held it in 1 quarter. The position peaked at $7.61M in Q2 2015. 130 funds tracked by Wall St. Rank hold DPLO as of Q3 2015.

  • Starboard Value reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2015 after selling out during the quarter.
  • Starboard Value sold 170,000 DIPLOMAT PHARMACY, INC. shares in Q3 2015, an estimated $7.61M.
  • Starboard Value first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 1 quarter.
  • Starboard Value's DIPLOMAT PHARMACY, INC. position peaked at $7.61M in Q2 2015.
  • 130 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2015.

Based on Starboard Value's 13F filing for Q3 2015, filed 13 Nov 2015.